Evidence map›Paper›PMID 17972921›Full record

ReviewGene therapy2007

Progress and prospects: targeted gene alteration (TGA).

H Parekh-Olmedo, E B Kmiec

Abstract readReview
PubMed Publisher
In one paragraph

Review in Gene therapy, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. CRISPR-DirectedThe CRISPR journal · 2018
    Article
  6. Article
  7. Article
  8. Review
  9. The Development of TALE Nucleases for Biotechnology.Methods in molecular biology (Clifton, N.J.) · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Transplantation of gene-corrected motor neurons as a therapeutic strategy for spinal muscular atrophy.Molecular therapy : the journal of the American Society of Gene Therapy · 2013
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

H Parekh-OlmedoDepartment of Biological Sciences, Delaware Biotechnology Institute, University of Delaware, Newark, DE 19711, USA.
E B Kmiec

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Targeted gene repair or targeted gene alteration is a molecular strategy that aims to correct single base mutations responsible for genetic diseases. The concept involves using single-stranded DNA oligonucleotides to direct a nucleotide exchange reaction at the genomic site of the mutation. Investigators have made significant progress in elucidating the mechanism(s) by which the mutation is corrected and have begun to focus on several viable targets that show great potential for clinical application. During the past several years, the field has witnessed a phase transition as the focus has switched from purely basic science to a sustained translational mode. We highlight the important advances over the last two to three years, some of which have moved the technology closer to the clinic while some others have introduced new reasons for caution.

Indexed as

AnimalsBase Pair MismatchDNA RepairGenetic Diseases, InbornGenomeHumansTargeted Gene Repair

Identifiers

PMID17972921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.